Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes

Cardiovascular Research

Volumn 83, Issue 1, 2009, Pages 148-154

  Rutkai, Ibolya ^a   Feher, Attila ^a   Erdei, Nora ^a   Henrion, Daniel ^b   Papp, Zoltan ^a   Edes, Istvan ^a   Koller, Akos ^c,d   Kaley, Gabor ^c   Bagi, Zsolt ^a,c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITÉ D'ANGERS   (France)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Arteriole; Diabetes; EP receptor; Hypertension; Prostanoid

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ANGIOTENSIN II; LEPTIN RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PTGER1 PROTEIN, MOUSE; VASOCONSTRICTOR AGENT; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; GRACILIS MUSCLE; HETEROZYGOTE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; ANIMAL; BLOOD PRESSURE; DIABETES MELLITUS; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; HYPERTENSION; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; VASCULAR RESISTANCE; VASCULARIZATION;

ANGIOTENSIN II; ANIMALS; ARTERIOLES; BLOOD PRESSURE; DIABETES MELLITUS; DINOPROSTONE; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; MICE; MICE, MUTANT STRAINS; MUSCLE, SKELETAL; PROSTAGLANDIN ANTAGONISTS; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; XANTHONES;

EID: 67649327410     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp098     Document Type: Article

References (39)

1. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001;37:1053-1059.
2. Kirpichnikov D, Sowers JR. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metab 2001;12:225-230.
3. Heistad DD, Lopez JA, Baumbach GL. Hemodynamic determinants of vascular changes in hypertension and atherosclerosis. Hypertension 1991;17:III7-11.
4. Mulvany MJ. Structure and function of small arteries in hypertension. J Hypertens Suppl 1990;8:S225-S232.
5. Schmid-Schonbein GW, Zweifach BW, DeLano FA, Chen PC. Microvascular tone in a skeletal muscle of spontaneously hypertensive rats. Hypertension 1987;9:164-171.
6. Bohlen HG. Arteriolar closure mediated by hyperresponsiveness to norepinephrine in hypertensive rats. Am J Physiol 1979;236:H157- H164.
7. Koller A. Signaling pathways of mechanotransduction in arteriolar endothelium and smooth muscle cells in hypertension. Microcirculation 2002;9:277-294.
8. Jaap AJ, Shore AC, Tooke JE. The influence of hypertension on microvascular blood flow and resistance to flow in the skin of patients with type 2 (non-insulin-dependent) diabetes. Diabet Med 1994;11:883- 887.
9. Lagaud GJ, Masih-Khan E, Kai S, van Breemen C, Dube GP. Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries. J Vasc Res 2001;38:578-589.
10. Naik JS, Xiang L, Hester RL. Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2006;290:R154-R161.
11. Bagi Z, Erdei N, Toth A, Li W, Hintze TH, Koller A et al. Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins. Arterioscler Thromb Vasc Biol 2005;25:1610-1616.
12. Bagi Z, Koller A, Kaley G. Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 2003;285:H1404-H1410.
13. Bagi Z, Koller A, Kaley G. PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes. Am J Physiol Heart Circ Physiol 2004;286:H742-H748.
14. Guo Z, Su W, Allen S, Pang H, Daugherty A, Smart E et al. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 2005;67:723-735.
15. Bishop-Bailey D, Pepper JR, Larkin SW, Mitchell JA. Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: role of endogenous prostanoids. Arterioscler Thromb Vasc Biol 1998;18:1655-1661.
16. Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br J Pharmacol 1997;121:125-133.
17. Campean V, Theilig F, Paliege A, Breyer M, Bachmann S. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol 2003;285:F19-F32.
18. Schneider A, Zhang Y, Zhang M, Lu WJ, Rao R, Fan X et al. Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney. Kidney Int 2004;65:1205-1213.
19. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001;41:661- 690.
20. Guan Y, Zhang Y, Wu J, Qi Z, Yang G, Dou D et al. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J Clin Invest 2007;117:2496-2505.
21. Suganami T, Mori K, Tanaka I, Mukoyama M, Sugawara A, Makino H et al. Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats. Hypertension 2003;42:1183-1190.
22. Oliva P, Berrino L, de Novellis V, Palazzo E, Marabese I, Siniscalco D et al. Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia. Eur J Pharmacol 2006;530:40-47.
23. Siddiqui AH, Hussain T. Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats. Am J Physiol Heart Circ Physiol 2007;292:H1722-H1727.
24. Stas SN, El-Atat FA, Sowers JR. Pathogenesis of hypertension in diabetes. Rev Endocr Metab Disord 2004;5:221-225.
25. Hsueh WA, Quinones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol 2003;92:10J-17J.
26. Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 2007;4:84-88.
27. Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N et al. The effects of cyclooxygenase-2 inhibitors and nonsteroidal antiinflammatory therapy on 24 h blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med 2005;165:161-168.
28. White WB, Kent J, Taylor A, Verburg KM, Lefkowith JB, Whelton A. Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension 2002;39:929-934.
29. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD et al. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 2002;110:61-69.
30. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79:1193-1226.
31. 2 in the rat cremaster muscle. Adv Prostaglandin Thromboxane Res 1980;7:719-722.
32. Bolla M, You D, Loufrani L, Levy BI, Levy-Toledano S, Habib A et al. Cyclooxygenase involvement in thromboxane-dependent contraction in rat mesenteric resistance arteries. Hypertension 2004;43:1264-1269.
33. Sametz W, Prasthofer S, Wintersteiger R, Juan H. Vascular effects of isoprostanes after endothelial damage. Prostaglandins Leukot Essent Fatty Acids 1999;61:369-372.
34. Breyer MD, Breyer RM. G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol 2001;63:579-605.
35. 2. Am J Physiol 1999;277:H924-H930.
36. Zhang Y, Guan Y, Schneider A, Brandon S, Breyer RM, Breyer MD. Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors. Hypertension 2000;35:1129-1134.
37. 2 in hypertensive and normotensive rats. Eur J Pharmacol 1976;39:251-258.
38. Gerber JG, Nies AS. The hemodynamic effects of prostaglandins in the rat. Evidence for important species variation in renovascular responses. Circ Res 1979;44:406-410.
39. 2 EP1 receptor mediates pain perception and regulates blood pressure. J Clin Invest 2001;107:325-331.